194 related articles for article (PubMed ID: 35226250)
1. AS3MT facilitates NLRP3 inflammasome activation by m
Qiu T; Wu C; Yao X; Han Q; Wang N; Yuan W; Zhang J; Shi Y; Jiang L; Liu X; Yang G; Sun X
Cell Biol Toxicol; 2023 Oct; 39(5):2165-2181. PubMed ID: 35226250
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 inhibition facilitates NLRP3 inflammasome activation in arsenic-induced insulin resistance in rat liver.
Wu C; Qiu T; Yuan W; Shi Y; Yao X; Jiang L; Zhang J; Yang G; Liu X; Bai J; Zhao D; Sun X
Environ Toxicol Pharmacol; 2022 Nov; 96():103981. PubMed ID: 36182042
[TBL] [Abstract][Full Text] [Related]
3. Arsenic induces hepatic insulin resistance via mtROS-NLRP3 inflammasome pathway.
Jia X; Qiu T; Yao X; Jiang L; Wang N; Wei S; Tao Y; Pei P; Wang Z; Zhang J; Zhu Y; Yang G; Liu X; Liu S; Sun X
J Hazard Mater; 2020 Nov; 399():123034. PubMed ID: 32544768
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome blocked the glycolytic pathway via targeting to PKLR in arsenic-induced hepatic insulin resistance.
Zhang J; Qiu T; Jiang L; Wang N; Zhu Y; Yan R; Wang S; Bai J; Shi X; Yang G; Liu X; Yao X; Sun X
Ecotoxicol Environ Saf; 2021 Oct; 223():112590. PubMed ID: 34364127
[TBL] [Abstract][Full Text] [Related]
5. Hsp47 acts as a bridge between NLRP3 inflammasome and hepatic stellate cells activation in arsenic-induced liver fibrosis.
Yuan W; Qiu T; Yao X; Wu C; Shi Y; Wang N; Zhang J; Jiang L; Liu X; Yang G; Bai J; Sun X
Toxicol Lett; 2022 Nov; 370():7-14. PubMed ID: 35963424
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels.
Quezada N; Valencia I; Torres J; Maturana G; Cerda J; Arab JP; Fuentes JJ; Pinto C; Turiel D; Cortés V
BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941551
[TBL] [Abstract][Full Text] [Related]
7. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C
Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitinated gasdermin D mediates arsenic-induced pyroptosis and hepatic insulin resistance in rat liver.
Zhu Y; Zhang J; Yao X; Qiu T; Jiang L; Wang N; Shi Y; Wu C; Yuan W; Yang G; Liu X; Bai J; Men L; Sun X
Food Chem Toxicol; 2022 Feb; 160():112771. PubMed ID: 34920032
[TBL] [Abstract][Full Text] [Related]
10. Filamin A facilitates NLRP3 inflammasome activation during arsenic-induced nonalcoholic steatohepatitis.
Shi Y; Qiu T; Wu C; Yuan W; Yao X; Jiang L; Wang N; Wang L; Han Q; Yang G; Liu X; Sun X
Environ Sci Pollut Res Int; 2023 Oct; 30(49):107703-107715. PubMed ID: 37740811
[TBL] [Abstract][Full Text] [Related]
11. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
12. Autophagic-CTSB-inflammasome axis modulates hepatic stellate cells activation in arsenic-induced liver fibrosis.
Tao Y; Qiu T; Yao X; Jiang L; Wang N; Jia X; Wei S; Wang Z; Pei P; Zhang J; Zhu Y; Yang G; Liu X; Liu S; Sun X
Chemosphere; 2020 Mar; 242():124959. PubMed ID: 31669990
[TBL] [Abstract][Full Text] [Related]
13. METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner.
Cao F; Chen G; Xu Y; Wang X; Tang X; Zhang W; Song X; Yang X; Zeng W; Xie J
Cell Death Dis; 2024 Jan; 15(1):43. PubMed ID: 38218935
[TBL] [Abstract][Full Text] [Related]
14. Nod-like receptor protein 3 inflammasome-mediated pyroptosis contributes to chronic NaAsO
Jin Y; Song Q; He R; Diao H; Gaoyang H; Wang L; Fan L; Wang D
Ecotoxicol Environ Saf; 2024 Apr; 275():116282. PubMed ID: 38564859
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
16. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
17. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
18. STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome.
Xiao Y; Zhao C; Tai Y; Li B; Lan T; Lai E; Dai W; Guo Y; Gan C; Kostallari E; Tang C; Gao J
Redox Biol; 2023 Jun; 62():102691. PubMed ID: 37018971
[TBL] [Abstract][Full Text] [Related]
19. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism.
Wan X; Xu C; Lin Y; Lu C; Li D; Sang J; He H; Liu X; Li Y; Yu C
J Hepatol; 2016 Apr; 64(4):925-32. PubMed ID: 26639394
[TBL] [Abstract][Full Text] [Related]
20. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
Kim DH; Kim SM; Lee B; Lee EK; Chung KW; Moon KM; An HJ; Kim KM; Yu BP; Chung HY
J Nutr Biochem; 2017 Jul; 45():104-114. PubMed ID: 28499186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
